Table 3 Comparison of incidence of in-hospital adverse events in patients with elevated RBG, elevated FBG and control group
Variables | Elevated RBG group | Normal RBG group | P value | Elevated FBG group | Normal FBG group | P value |
|---|---|---|---|---|---|---|
Death | 56 (265) | 24 (693) | < 0.001* | 72 (589) | 5 (369) | < 0.001* |
Nonfatal recurrent myocardial infarction | 6 (265) | 4 (693) | 0.052 | 7 (589) | 3 (369) | 0.818 |
Stroke | 1 (265) | 0 (693) | 0.617 | 1 (589) | 0 (369) | 1 |
Hemorrhage | 9 (265) | 14 (693) | 0.014* | 20 (589) | 3 (369) | 0.013* |
Cardiac shock | 57 (265) | 49 (693) | < 0.001* | 89 (589) | 17 (369) | < 0.001* |
Malignant arrhythmia | 25 (265) | 13 (693) | < 0.001* | 32 (589) | 6 (369) | 0.003* |